dorsaVi (ASX: DVL) has taken a significant step toward the next generation of intelligent wearables and robotics with the acquisition of a neuromorphic technology portfolio from researchers at Technion – Israel Institute of Technology, led by Professor Shahar Kvatinsky, a global authority in Processing-in-Memory and adaptive hardware systems. …
dorsaVi secures breakthrough neuromorphic technology to power next-generation wearables and robotics
November 12, 2025 Australian Biotech
Latest Video
New Stories
-
RAGE Biotech raises $29 million and appoints new leadership to advance precision RNA therapeutics
November 13, 2025 - - Latest News -
Nanosonics names new North American president ahead of CORIS launch
November 13, 2025 - - Australian Biotech -
Australians open to AI in healthcare, but prefer doctors to be in control
November 13, 2025 - - Latest News -
Every Government agency to appoint a 'Chief AI Officer' under national plan
November 12, 2025 - - Latest News -
New Zealand accelerates medicines reform with major regulatory changes
November 12, 2025 - - Latest News -
FDA moves to lift long-standing hormone therapy warnings in major shift for women’s health
November 12, 2025 - - Latest News -
Optometry Australia and Alcon launch scholarship fund to support First Nations eye health leaders
November 12, 2025 - - Latest News